Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Senseonics Holdings Inc
SENS
$503M
| $485K | ﹤0.01% |
13,535
+1,149
| +9% | +$55.5K |
|
2827
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.7B
| $485K | ﹤0.01% |
+10,145
| New | +$483K |
|
|
EVOL
2828
DELISTED
Evolving Systems, Inc.
EVOL
| $485K | ﹤0.01% |
100,066
+66
| +0.1% | +$297 |
|
2829
Spok Holdings
SPOK
$221M
| $484K | ﹤0.01% |
+25,465
| New | +$494K |
|
|
AAC
2830
DELISTED
AAC Holdings
AAC
| $483K | ﹤0.01% |
56,659
-115,388
| -67% | -$944K |
|
2831
Walker & Dunlop
WD
$1.4B
| $482K | ﹤0.01% |
+11,569
| New | +$427K |
|
2832
Axogen
AXGN
$2.68B
| $481K | ﹤0.01% |
+45,987
| New | +$469K |
|
2833
BCB Bancorp
BCBP
$157M
| $481K | ﹤0.01% |
+28,873
| New | +$423K |
|
2834
Univest Financial
UVSP
$1.14B
| $481K | ﹤0.01% |
18,560
+8,960
| +93% | +$251K |
|
2835
Vanguard Health Care ETF
VHT
$19.8B
| $481K | ﹤0.01% |
3,488
-12
| -0.3% | -$1.62K |
|
|
TA
2836
DELISTED
TravelCenters of America LLC
TA
| $480K | ﹤0.01% |
15,737
-30,071
| -66% | -$1.01M |
|
2837
iShares MSCI EAFE Growth ETF
EFG
$17.3B
| $479K | ﹤0.01% |
+6,889
| New | +$461K |
|
2838
Vermilion Energy
VET
$1.86B
| $479K | ﹤0.01% |
12,764
-9,936
| -44% | -$393K |
|
|
PBNC
2839
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
| $479K | ﹤0.01% |
+8,949
| New | +$434K |
|
|
BCIC
2840
BCP Investment Corp
BCIC
$95.7M
| $478K | ﹤0.01% |
11,748
+5,971
| +103% | +$240K |
|
|
CLVS
2841
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $478K | ﹤0.01% |
7,500
| – | – |
|
|
MB
2842
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $478K | ﹤0.01% |
17,415
-76,447
| -81% | -$1.97M |
|
2843
Miller Industries
MLR
$649M
| $477K | ﹤0.01% |
+18,093
| New | +$462K |
|
2844
Corvus Pharmaceuticals
CRVS
$1.22B
| $475K | ﹤0.01% |
22,853
-36,034
| -61% | -$564K |
|
2845
New York Times
NYT
$11.1B
| $475K | ﹤0.01% |
32,979
-190,956
| -85% | -$2.73M |
|
2846
LivePerson
LPSN
$34.2M
| $474K | ﹤0.01% |
4,616
-853
| -16% | -$91.2K |
|
2847
Vanguard Total World Stock ETF
VT
$81.2B
| $473K | ﹤0.01% |
7,248
-4,182
| -37% | -$267K |
|
|
VSA
2848
VisionSys AI
VSA
$9.44M
| $473K | ﹤0.01% |
10
-79
| -89% | -$3.18M |
|
2849
Consolidated Water Co
CWCO
$482M
| $472K | ﹤0.01% |
40,524
-24,703
| -38% | -$261K |
|
|
RVNC
2850
DELISTED
Revance Therapeutics, Inc.
RVNC
| $472K | ﹤0.01% |
22,705
-27,797
| -55% | -$571K |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.